Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (Unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS EQUITY (Unaudited) - 6 months ended Jun. 30, 2018 - USD ($)
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Noncontrolling Interest
Total
Beginning Balance, Amount at Dec. 31, 2017 $ 27,357 $ 25,185,487 $ (249,265) $ (13,989,018) $ 510,782 $ 11,485,343
Beginning Balance, Shares at Dec. 31, 2017 27,356,838   189,020      
Common stock previously issued and canceled, Amount $ (72) (67,929) (68,001)
Common stock previously issued and canceled, Shares (71,667)        
Common stock issued for services rendered, Amount $ 35 44,541 $ 44,576
Common stock issued for services rendered, Shares 34,371       34,371
Common stock previously issued returned to treasury and canceled, Amount $ (189) (249,076) $ 249,265
Common stock previously issued returned to treasury and canceled, Shares (189,020)   (189,020)      
Sale of common sock, Amount $ 5,000 7,495,000 7,500,000
Sale of common sock,Shares 5,000,000        
Reclassify put option in connection to sale of common stock to temporary equity (7,500,000) (7,500,000)
Acquisition of Crane Creek Surgery Center (129,389) (270,611) (400,000)
Stock based compensation , Amount $ 350 295,943 $ 296,293
Stock based compensation,Shares 350,000       350,000
Net income 710,887 55,756 $ 766,643
Ending Balance, Amount at Jun. 30, 2018 $ 32,481 $ 25,074,577 $ (13,278,131) $ 295,927 $ 12,124,854
Ending Balance, Shares at Jun. 30, 2018 32,480,522